{"id":"W3189922281","doi":"10.1358/dot.2021.57.8.3293588","title":"Vibegron: a beta3-adrenergic agonist for the treatment ofoveractive bladder","year":2021,"lang":"en","type":"article","venue":"Drugs of today","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Nocturia; Medicine; Overactive bladder; Anticholinergic; Agonist; Oxybutynin; Urology; Urinary urgency; Urinary incontinence; Anticholinergic agents; Urinary bladder; Adrenergic; Urinary system; Mirabegron; Internal medicine; Receptor; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001552527,0.0001314244,0.0002676609,0.00003964985,0.0001329282,0.00002063187,0.00008307878,0.00005246004,0.0006026862],"category_scores_gemma":[0.00004780742,0.00007995139,0.0002328494,0.0001416775,0.00009829697,0.00005080278,0.00003830389,0.0001034888,0.00002299503],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007847748,"about_ca_system_score_gemma":0.000331815,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001387462,"about_ca_topic_score_gemma":0.00002115175,"domain_scores_codex":[0.9990028,0.00004662978,0.0001810886,0.0002330943,0.0002695617,0.0002668672],"domain_scores_gemma":[0.998722,0.0005066742,0.00005039331,0.0003978751,0.0002267381,0.0000963728],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01125465,0.01290449,0.006757481,0.001203709,0.01171638,0.00106795,0.03911892,0.0003183499,0.0784123,0.01001774,0.08103118,0.7461969],"study_design_scores_gemma":[0.006104803,0.002965131,0.008297634,0.0000751627,0.0006836118,0.0001029844,0.003799172,0.0006108513,0.3814734,0.0007984676,0.5948601,0.0002286904],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8163629,0.02170094,0.000629499,0.04644601,0.0007646077,0.003339697,0.0005728991,0.00009657717,0.1100869],"genre_scores_gemma":[0.967151,0.001905414,0.0005759759,0.0003005902,0.0002673636,0.000158536,0.0001326885,0.00002625417,0.02948217],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7459682,"threshold_uncertainty_score":0.6598991,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02997721073690499,"score_gpt":0.3314776276383604,"score_spread":0.3015004169014553,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}